Albany ENT is conducting a clinical research study to evaluate SeptAlign®, a minimally invasive alternative for the correction of nasal septal deviation.
You may qualify if you are:
- ≥21 to ≤64 years of age at the time of consent
- Seeking treatment for nasal airway obstruction symptoms due primarily to nasal septal deviation
- Willing to undergo a nasal implant procedure. Implant is cleared for commercial use by FDA
- A non-smoker or have a history of tobacco or tobacco-related product use within 1 year
- A non-user of systemic steroid and/or recreational intra-nasal drugs
- Free from symptoms of an upper respiratory infection (e.g., runny nose, sneezing)
Qualified participants will receive the study procedure at no cost. Compensation for time and travel may be available. To learn more or schedule an appointment, contact Albany ENT today!
Please call us at 518-701-2085 for more information.